文献速递腹部泌尿生殖MR

直肠癌新辅助放化疗后MRI评估图解指南

Rectal MRI after neoadjuvant chemoradiation therapy: a pictorial guide to interpretation.
PubMed 文献 · Abdom Radiol (NY) · 2021-03-02

本文为图谱式综述,展示直肠癌新辅助放化疗后MRI评估的关键影像特征,包括残余肿瘤(非黏液性、黏液性及印戒细胞腺癌亚型)的MRI表现并与组织病理学对照,同时展示模拟残余肿瘤的治疗后改变及治疗并发症。熟悉这些影像表现有助于放射科医师遵循SAR直肠癌疾病专注小组和ESGAR提出的结构化报告模板。

要点

  • 残余肿瘤MRI表现因腺癌亚型而异,非黏液性、黏液性及印戒细胞亚型需分别识别。
  • 病理完全缓解者可出现模拟残余肿瘤的治疗后改变,需注意鉴别。
  • 熟悉治疗后MRI表现有助于完成SAR和ESGAR结构化报告模板的全部要素。

关键影像表现/征象

  • 残余肿瘤包括非黏液性、黏液性及印戒细胞腺癌亚型,其MRI表现与组织病理学相关。
  • 在切除标本证实病理完全缓解的病例中,部分治疗后改变可模拟残余肿瘤。
  • 文中亦展示了治疗并发症的影像表现。

临床应用与阅片要点

  • 阅片时应识别残余肿瘤的不同腺癌亚型MRI表现,并与治疗后改变鉴别。
  • 报告可参照SAR直肠癌疾病专注小组和ESGAR提出的结构化报告模板要素。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Magnetic resonance imaging (MRI) is the current reference standard imaging modality for restaging rectal cancer after neoadjuvant chemoradiation and is used to guide clinical management decisions. This pictorial essay provides an illustrative atlas of the key MRI features used to assess rectal cancer after treatment. MRI findings of residual tumor including non-mucinous, mucinous, and signet-ring cell adenocarcinoma subtypes are correlated with histopathology. Imaging appearances of treatment changes that mimic residual tumor in the setting of confirmed pathological complete response at resection are illustrated. Treatment complications are also shown. Knowledge of these imaging findings and their importance may help radiologists comply with all elements of the structured reporting templates proposed by the Rectal Cancer Disease Focused Panel of the Society of Abdominal Radiology and by the European Society of Gastrointestinal and Abdominal Radiology.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Almeida RR, Souza D, Matalon SA, et al. Rectal MRI after neoadjuvant chemoradiation therapy: a pictorial guide to interpretation. Abdom Radiol (NY). 2021. PMID: 33651124. doi:10.1007/s00261-021-03007-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。